| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/21/2010 | CN101779886A Cervical-vertebra health care pillow, pillowcase and medicine bag |
| 07/21/2010 | CN101779882A Traditional Chinese medicinal pillow and production method thereof |
| 07/21/2010 | CN101317995B Medicament for treating ischemic necrosis of femoral head and preparation method thereof |
| 07/21/2010 | CN101239159B Chinese medicinal composition for treating rheumatoild disease and preparation thereof |
| 07/21/2010 | CN101204487B Chinese traditional medicine for fracture |
| 07/21/2010 | CN101199750B Chinese medicine prescription for treating hyperuricemia |
| 07/21/2010 | CN101181631B Compound prescription for preventing and improving osteosporosis as well as preparation method thereof |
| 07/21/2010 | CN101049387B Composition of Chinese traditional medicine for treating rheumatic bone disease |
| 07/20/2010 | US7759486 2,4,5-Trisubstituted pyrimidine compounds |
| 07/20/2010 | US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 07/20/2010 | US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 07/20/2010 | US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7758858 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 07/20/2010 | CA2486399C Calcium receptor modulating agents |
| 07/20/2010 | CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 07/20/2010 | CA2447865C Novel sulfonic acid derivatives |
| 07/20/2010 | CA2399001C Integrin expression inhibitor |
| 07/15/2010 | WO2010079811A1 Gene sensitive to diseases associated with intervertebral disc degeneration, and use thereof |
| 07/15/2010 | WO2010079668A1 Olefin compound |
| 07/15/2010 | WO2010079514A1 A process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate |
| 07/15/2010 | WO2010078730A1 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection |
| 07/15/2010 | WO2010045755A8 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 07/15/2010 | US20100179304 Somatostatin-Dopamine Chimeric analogs |
| 07/15/2010 | US20100179208 Use of HDAC Inhibitors for the Treatment of Bone Destruction |
| 07/15/2010 | US20100179177 Heterocyclic compounds and their uses |
| 07/15/2010 | US20100179169 which is ketoconazole; gout flares |
| 07/15/2010 | US20100179168 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists |
| 07/15/2010 | US20100179167 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| 07/15/2010 | US20100179158 Inhibitors of cyclic amp phosphodiesterases |
| 07/15/2010 | US20100179146 Indolinone Compounds as Kinase Inhibitors |
| 07/15/2010 | US20100179141 Novel jnk inhibitors |
| 07/15/2010 | US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 07/15/2010 | US20100179124 Thieno-pyridine derivatives as mek inhibitors |
| 07/15/2010 | US20100179110 Composition Containing a Bisphosphonic Acid in Combination with Vitamin D |
| 07/15/2010 | US20100179107 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 07/15/2010 | US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 07/15/2010 | US20100178355 Method for in situ solidification of blood-polymer compositions for regenerative medicine and cartilage repair applications |
| 07/15/2010 | US20100178346 Disc augmentation with hyaluronic acid |
| 07/15/2010 | US20100178344 Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles |
| 07/15/2010 | US20100178314 Freeze-dried fibrin matrices and methods for preparation thereof |
| 07/15/2010 | US20100178296 Antibodies to cd200r |
| 07/15/2010 | US20100178280 Use of sirt7 for treating age-related diseases |
| 07/15/2010 | US20100178274 Application of synovium-derived mesenchymal stem cells (mscs) for cartilage or meniscus regeneration |
| 07/15/2010 | US20100178250 Method of Local Delivery of Bioactive and Diagnostic Agents Using Magnetizable Bone Cement |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/14/2010 | EP2206725A1 Analogs of parathyroid hormone |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206511A1 Protein a compositions and methods of use |
| 07/14/2010 | EP2206501A2 HMGA binding nucleic acids |
| 07/14/2010 | EP2205722A2 Method for stimulating the proliferation of differentiated cells belonging to the chondrogenic lineage |
| 07/14/2010 | EP2205598A1 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 07/14/2010 | EP2205592A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/14/2010 | EP2205269A1 Therapeutic uses of intermedin 47 and 53 peptides |
| 07/14/2010 | EP2205265A1 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
| 07/14/2010 | EP2205254A1 Method of producing plant extract formulations |
| 07/14/2010 | CN101775058A Preparation and application of pharmaceutic preparation of 11-carbonyl-betal- acetyl mastic acid and derivatives thereof extracted from frankincense |
| 07/14/2010 | CN101773671A Application of shRNA (short hairpin Ribonucleic Acid) of Periostin gene in preparing medicament for inhibiting tumor |
| 07/14/2010 | CN101773664A Fish bone scale collagen peptide for preventing and curing egg and poultry fracture |
| 07/14/2010 | CN101773663A New application of collagen chelate |
| 07/14/2010 | CN101773654A Herbal paste for treatment of femoral head necrosis and manufacturing process thereof |
| 07/14/2010 | CN101773642A Gukangling plaster formula for activating blood and dissolving stasis and preparation method |
| 07/14/2010 | CN101773608A Medicine for treating rheumatoid arthritis or resembling rheumatoid arthritis and usage |
| 07/14/2010 | CN101773583A Anti-spur Chinese medicine preparation and preparation method thereof |
| 07/14/2010 | CN101773577A Kanto tea bath package for curing rheumatism, arthritis and senile degenerative joint diseases |
| 07/14/2010 | CN101773575A Bone-strengthening and muscle-relaxing medicine |
| 07/14/2010 | CN101773561A Chinese medicine composition with functions of tonifying kidney, invigorating blood circulation and relieving pain and preparation method thereof |
| 07/14/2010 | CN101773551A External-use medicine composition of traditional Mongolian medicine for curing soft tissue injury |
| 07/14/2010 | CN101773539A Prescription with function for mitigating and curing osteoarthrosis |
| 07/14/2010 | CN101773537A Slow-release microspheres prepared from active ingredients of tripterygium wilfordii and preparation method thereof |
| 07/14/2010 | CN101773531A Medicinal liquor for treating osteoproliferation and femoral head necrosis |
| 07/14/2010 | CN101773498A Oral slow/controlled-release preparation containing febuxostat and preparation method thereof |
| 07/14/2010 | CN101773490A Active part of Sambucus williamsii Hance for reducing risk of bone-related diseases of menopausal women and application thereof |
| 07/14/2010 | CN101773353A Cervical vertebra rehabilitation medicinal pillow |
| 07/14/2010 | CN101773306A Far-infrared pure-cotton Colopo knee guard |
| 07/14/2010 | CN101214318B Medicinal liquor for treating rheumatism, rheumatoid and various hyperosteogeny |
| 07/14/2010 | CN101190256B Chuanqisan for treating cervical spondylopathy and preparation method |
| 07/14/2010 | CN101112391B Application of HGF transgenic bone marrow stroma stem cell in the preparation of bone restoring material |
| 07/13/2010 | US7756643 Method for determining the biological effect and/or activity of at least one drug, chemical substances and/or pharmaceutical composition based on their effect on the methylation status of DNA |
| 07/13/2010 | US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 07/13/2010 | US7754751 Preferential inhibition of release of pro-inflammatory cytokines |
| 07/13/2010 | US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12) |
| 07/13/2010 | US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2) |
| 07/13/2010 | US7754709 Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
| 07/13/2010 | US7754701 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries |
| 07/13/2010 | US7754255 Bone metabolism improving agent |
| 07/13/2010 | US7754228 Cytotoxic T-cell epitopes from Chlamydia |
| 07/13/2010 | US7754200 Phosphate transport inhibitors |
| 07/13/2010 | CA2557536C Amino alcohol compound |
| 07/13/2010 | CA2448303C Biologically active methylene blue derivatives |
| 07/13/2010 | CA2446820C Novel pyrrole derivatives as pharmaceutical agents |
| 07/13/2010 | CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 07/13/2010 | CA2432145C Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/13/2010 | CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 07/13/2010 | CA2410885C Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases |
| 07/13/2010 | CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/13/2010 | CA2372443C Local administration of anti-malarial agents for the treatment of inflammatory diseases |
| 07/13/2010 | CA2345932C Peptide-based carrier devices for stellate cells |